Emerson Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Emerson Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$9.82M	Sell	153,767 -6,979	-4%	-$440K	1.86%	12
2015 Q4	$11.1M	Buy	160,746 +749	+0.5%	+$49.5K	2.16%	7
2015 Q3	$9.47M	Buy	159,997 +7,325	+5%	+$465K	1.89%	10
2015 Q2	$10.2M	Sell	152,672 -1,273	-0.8%	-$83.9K	1.9%	7
2015 Q1	$9.93M	Buy	153,945 +7,651	+5%	+$479K	1.81%	10
2014 Q4	$8.64M	Buy	146,294 +1,055	+0.7%	+$59.5K	1.68%	15
2014 Q3	$7.43M	Buy	145,239 +32,420	+29%	+$1.62M	1.47%	21
2014 Q2	$5.47M	Sell	112,819 -1,635	-1%	-$80.6K	1.07%	34
2014 Q1	$5.95M	Sell	114,454 -2,849	-2%	-$152K	1.22%	29
2013 Q4	$6.24M	Sell	117,303 -4,478	-4%	-$228K	1.31%	29
2013 Q3	$5.64M	Sell	121,781 -5,204	-4%	-$228K	1.26%	29
2013 Q2	$5.67M	Buy	+126,985	New	+$5.51M	1.32%	28

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Emerson Investment Management's BMY Position: Q1 2016 in Review

Emerson Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 4.3% in Q1 2016, selling an estimated $440K and leaving 153,767 shares worth $9.82M. The position accounts for 1.86% of the portfolio, ranked #12.

Emerson Investment Management first reported a position in BMY in Q2 2013 and has held it in 12 quarters since. The position peaked at $11.1M in Q4 2015. 1,524 funds tracked by Wall St. Rank hold BMY as of Q1 2016.

Emerson Investment Management held 153,767 shares of Bristol-Myers Squibb worth $9.82M as of Q1 2016.
Emerson Investment Management sold 6,979 Bristol-Myers Squibb shares in Q1 2016, an estimated $440K.
Bristol-Myers Squibb made up 1.86% of Emerson Investment Management's portfolio in Q1 2016, its #12 holding.
Emerson Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 12 quarters since.
Emerson Investment Management's Bristol-Myers Squibb position peaked at $11.1M in Q4 2015.
1,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.

Based on Emerson Investment Management's 13F filing for Q1 2016, filed 9 May 2016.